Ondine Biomedical Inc.
OBIMF
$0.25
$0.0847.06%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.21% | -48.14% | -60.02% | -52.00% | -69.18% |
| Total Depreciation and Amortization | 0.00% | -1.36% | 7.90% | 2.56% | -3.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.24% | 14.63% | 7.88% | 2.44% | 1,695.86% |
| Change in Net Operating Assets | 13.02% | 11.48% | 8,620.29% | 8,187.14% | 130.97% |
| Cash from Operations | -63.31% | -61.06% | -42.06% | -34.93% | -49.11% |
| Capital Expenditure | -- | -- | -135.14% | -127.03% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -135.14% | -127.03% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 78.11% | 78.11% | 2.68% | 2.68% | -242.59% |
| Issuance of Common Stock | 19.44% | 19.44% | -4.75% | -4.75% | 244.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.45% | 1.45% | 96.00% | 96.00% | -97.29% |
| Cash from Financing | 14.05% | 12.48% | 3.51% | -1.69% | 300.14% |
| Foreign Exchange rate Adjustments | -85.02% | -85.24% | 646.67% | 610.53% | 1,201.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.35% | -42.15% | -143.79% | -131.55% | 674.24% |